Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Hassan Mohammed Jawad Al-Khateeb – President of the Management Board
Manner of representation
Two members of the management board acting jointly, a member of the management board jointly with a commercial proxy, and, in the case of a one-person management board, the President of the Management Board independently are authorized to represent the company.
Supervisory board
Hasanain Naji Al-Taweel – Supervisory Board Member
Mirna Darwich – Supervisory Board Member
Ownership
| Owner | Share value | Stake |
|---|---|---|
| $27,012.43 | 100% |
Beneficial owners
No beneficial owners recorded for the company AL Olfa Group.
Bank accounts
Registered as a VAT taxpayer on 2022-10-25.
No bank accounts reported to the VAT Taxpayer Register.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
FAQ
Last updated: 2026-04-02